✦ LIBER ✦

The Safety Evaluation of Fluvastatin, an HMG–CoA Reductase Inhibitor, in Beagle Dogs and Rhesus Monkeys

✍ Scribed by Howard A. Hartman; Laurie A. Myers; Morton Evans; Rodney L. Robison; Robert G. Engstrom; Francis L.S. Tse

Book ID: 115608557
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 148 KB
Volume: 29
Category: Article
ISSN: 0272-0590
DOI: 10.1006/faat.1996.0005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of fluvastatin, an inhibitor

Disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in mouse, rat, dog, and monkey

✍ F. L. S. Tse; H. T. Smith; F. H. Ballard; J. Nicoletti 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The physiological disposition offluvastatin, a potent inhibitor of hydroxymethylglutaryl-CoA reductase and thus cholesterol synthesis, has been studied in the mouse, rat, dog, and monkey using 14C-or 3H-labeled drug. Oral doses of fluvastatin were absorbed at a moderate to rapid rate. The extent of

Absorption and disposition of fluvastati

Absorption and disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in the rabbit

✍ F. L. S. Tse; D. Labbadia 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

The absorption and disposition of fluvastatin have been studied in the female rabbit. In naive rabbits receiving a single oral dose (1 mg kg-I) of [3H]fluvastatin, absorption was rapid and amounted to c. 90 per cent compared with an intravenous reference dose. The drug was subject to considerable fi

Effect of the cholesterol absorption inh

Effect of the cholesterol absorption inhibitor SCH48461 in combination with the HMG-CoA reductase inhibitor lovastatin in rabbits, dogs and rhesus monkeys

✍ H.R. Davis; R.W. Watkins; B.G. Salisbury; D.S. Compton; E.J. Sybertz; R.E. Burri 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Fluvastatin (Sandoz compound XU 62-320-

Fluvastatin (Sandoz compound XU 62-320- lescol), an HMG-CoA reductase inhibitor, in treatment of patients with type II a hyperlipidemia — Its efficacy and safety

✍ S. Rywik; U. Klosiewicz-Latoszek; G. Broda; W.B. Szostak 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Effects of fluvastatin (XU 62-320), an H

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

✍ Jiana Yuan; Michael Y. Tsai; Janet Hegland; Donald B. Hunninghake 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 931 KB

Effects of fluvastatin, an HMG-CoA reduc

Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia

✍ Hsin-Bang Leu; Jaw-Wen Chen; Tao-Cheng Wu; Yu-An Ding; Shing-Jong Lin; Min-Ji Ch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB